Quick Answer
cbdMD, Inc. reported Operating Income Loss of -$2.16 million for the year ending 2025.
- cbdMD, Inc. showed an increase of +34.8% in Operating Income Loss from 2024 to 2025.
- This data is from cbdMD, Inc.'s annual report (Form 10-K), filed with the SEC on December 19, 2025.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2016: -$695.5 thousand | Q1 2017: -$211.3 thousand | Q2 2017: -$178.6 thousand | Q4 2017: -$1.30 million | Q1 2018: $1.62 million | Q2 2018: $627.3 thousand | Q4 2018: -$1.09 million | Q1 2019: -$2.03 million | Q2 2019: -$6.47 million | Q4 2019: -$6.11 million | Q1 2020: -$5.60 million | Q2 2020: -$1.34 million | Q4 2020: -$1.76 million | Q1 2021: -$4.17 million | Q2 2021: -$6.68 million | Q4 2021: -$25.15 million | Q1 2022: -$5.01 million | Q2 2022: -$33.13 million | Q4 2022: -$4.05 million | Q1 2023: -$1.40 million | Q2 2023: -$1.82 million | Q4 2023: -$1.07 million | Q1 2024: -$1.55 million | Q2 2024: -$382.0 thousand | Q4 2024: -$86.3 thousand | Q1 2025: -$485.8 thousand | Q2 2025: -$904.7 thousand | Q4 2025: -$286.3 thousand.
- Over the full 10 years of available data (2016 to 2025), cbdMD, Inc.'s Operating Income Loss has grown by 44.4%.
- Historical annual values: Fiscal year 2025: -$2.16 million | Fiscal year 2024: -$3.32 million | Fiscal year 2023: -$22.49 million | Fiscal year 2022: -$78.27 million | Fiscal year 2021: -$19.62 million | Fiscal year 2020: -$17.58 million | Fiscal year 2019: -$14.80 million | Fiscal year 2018: -$1.80 million | Fiscal year 2017: -$1.36 million | Fiscal year 2016: -$3.89 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: